Wall Street Experts
ver. ZuMIgo(08/25)
Dyne Therapeutics, Inc.
Rachunek Zysków i Strat
Przychody TTM (mln): 4
EBIT TTM (mln): -315
index |
0 |
1 |
2 |
3 |
4 |
5 |
6 |
7 |
8 |
9 |
10 |
11 |
12 |
13 |
14 |
15 |
16 |
17 |
Rok finansowy |
2007 |
2008 |
2009 |
2010 |
2011 |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Przychód (mln) |
3,103 |
3,549 |
2,468 |
2,323 |
1,585 |
3 |
3 |
1,466 |
842 |
1,366 |
506 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Przychód Δ r/r |
0.0% |
14.4% |
-30.5% |
-5.9% |
-31.8% |
-99.8% |
0.0% |
48766.7% |
-42.6% |
62.2% |
-63.0% |
-100.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
Marża brutto |
35.1% |
47.8% |
51.6% |
49.2% |
39.2% |
-8833.3% |
-38066.7% |
21.9% |
-140.9% |
-67.0% |
-479.4% |
0.0% |
-inf% |
-inf% |
-inf% |
-inf% |
-inf% |
0.0% |
EBIT (mln) |
605 |
709 |
-834 |
-11 |
-236 |
714 |
-318 |
-318 |
64 |
-640 |
-412 |
-5 |
-14 |
-59 |
-150 |
-171 |
-242 |
-344 |
EBIT Δ r/r |
0.0% |
17.2% |
-217.6% |
-98.7% |
2045.5% |
-402.5% |
-144.5% |
0.0% |
-120.1% |
-1100.0% |
-35.6% |
-98.8% |
188.3% |
324.2% |
155.8% |
14.0% |
41.6% |
42.0% |
EBIT (%) |
19.5% |
20.0% |
-33.8% |
-0.5% |
-14.9% |
23800.0% |
-10600.0% |
-21.7% |
7.6% |
-46.9% |
-81.4% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
Koszty finansowe (mln) |
384 |
427 |
415 |
363 |
357 |
0 |
97 |
67 |
546 |
625 |
616 |
0 |
0 |
0 |
0 |
3 |
0 |
0 |
EBITDA (mln) |
830 |
902 |
-173 |
734 |
-1,574 |
113 |
150 |
292 |
736 |
106 |
949 |
-5 |
-15 |
-59 |
-148 |
-171 |
-240 |
-344 |
EBITDA(%) |
26.7% |
25.4% |
-7.0% |
31.6% |
-99.3% |
3766.7% |
5000.0% |
19.9% |
87.4% |
7.8% |
187.5% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
Podatek (mln) |
-151 |
-75 |
315 |
197 |
-632 |
-627 |
-58 |
117 |
-474 |
-45 |
-610 |
-0 |
-1 |
-1 |
-0 |
-3 |
0 |
0 |
Zysk Netto (mln) |
264 |
174 |
-1,262 |
-234 |
-1,645 |
87 |
-356 |
-67 |
50 |
-1,240 |
76 |
-5 |
-14 |
-59 |
-149 |
-165 |
-236 |
-317 |
Zysk netto Δ r/r |
0.0% |
-34.1% |
-825.3% |
-81.5% |
603.0% |
-105.3% |
-509.2% |
-81.2% |
-174.6% |
-2580.0% |
-106.1% |
-106.3% |
181.4% |
333.9% |
154.2% |
10.7% |
42.8% |
34.5% |
Zysk netto (%) |
8.5% |
4.9% |
-51.1% |
-10.1% |
-103.8% |
2900.0% |
-11866.7% |
-4.6% |
5.9% |
-90.8% |
15.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
EPS |
0.15 |
0.2 |
-1.25 |
-1.95 |
-13.48 |
0.87 |
-3.56 |
-0.53 |
0.4 |
-9.61 |
0.47 |
-0.47 |
-0.3 |
-4.08 |
-2.93 |
-3.18 |
-3.95 |
-3.37 |
EPS (rozwodnione) |
0.15 |
0.2 |
-1.25 |
-1.93 |
-13.48 |
0.87 |
-3.56 |
-0.53 |
0.4 |
-9.61 |
0.47 |
-0.47 |
-0.3 |
-4.08 |
-2.93 |
-3.18 |
-3.95 |
-3.37 |
Ilośc akcji (mln) |
1,760 |
870 |
1,010 |
120 |
122 |
100 |
100 |
126 |
125 |
129 |
162 |
10 |
45 |
14 |
51 |
52 |
60 |
94 |
Ważona ilośc akcji (mln) |
1,760 |
870 |
1,010 |
121 |
122 |
100 |
100 |
126 |
126 |
129 |
162 |
10 |
45 |
14 |
51 |
52 |
60 |
94 |
Waluta |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |
USD |